| License: Allianz- bzw. Nationallizenz PDF - Published Version (173kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-376579
- DOI to cite this document:
- 10.5283/epub.37657
Abstract
Background: We recently identified galectin-3 (gal-3) as a new and strong fibroblast activator produced by colonic epithelial cells. Very little is known about the influence of gal-3 in inflammatory bowel disease. We, therefore, investigated the impact of gal-3 on dextran sodium sulfate (DSS)-induced colitis in a mouse model. Methods: Colonic lamina propria fibroblasts of healthy controls were ...

Owner only: item control page
Download Statistics